GSK sells vaccine laboratory activities to Nexelis
GSK has sold its GCLP-certified clinical bioanalytical laboratory located in Marburg, Germany to Canadian clinical research organization (CRO), Nexelis.
Archives for January 21, 2021
Oxford University weighing up how vaccine platform would need to adapt to deal with variants
The team behind the Oxford-AstraZeneca COVID-19 vaccine says it is carefully assessing the impact of new variants from the UK, South Africa and Brazil on vaccine immunity.
VBI Vaccines to begin Phase 1/2 study of coronavirus vaccine candidate
VBI Vaccines is due to start a Phase 1/2 study of a coronavirus vaccine candidate in Q1 2021, after a preclinical hamster challenge study demonstrated ‘robust immunogenicity and efficacy’.